Yongheng Shi Selected Research

Yongheng Shi Research Topics

Disease

4	Neoplasms (Cancer) 01/2021 - 10/2017
3	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2021
2	Inflammation (Inflammations) 01/2022 - 01/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 10/2017
1	Hypertension (High Blood Pressure) 04/2024
1	Autoimmune Diseases (Autoimmune Disease) 04/2024
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2022
1	Necrosis 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2020
1	Gallbladder Neoplasms (Gallbladder Cancer) 12/2019
1	Lymphoma (Lymphomas) 12/2017
1	Neoplasm Metastasis (Metastasis) 10/2017
1	Type 2 Diabetes Mellitus (MODY) 05/2014

Drug/Important Bio-Agent (IBA)

3	tyloxapol FDA Link 01/2022 - 01/2021
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 12/2021
2	Clofibrate FDA Link 01/2022 - 01/2021
2	CholesterolIBA 01/2022 - 12/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2017
1	Prostaglandin H2 Thromboxane A2 ReceptorsIBA 04/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2024
1	ResveratrolIBA 04/2024
1	Sirtuin 1IBA 04/2024
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2024
1	Endothelin Receptors (Endothelin Receptor)IBA 12/2022
1	Fenofibrate (CiL)FDA LinkGeneric 12/2021
1	LipidsIBA 12/2021
1	sesaminIBA 12/2021
1	sesamolIBA 01/2021
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2021
1	AntioxidantsIBA 01/2021
1	Clofibric AcidIBA 01/2021
1	MethyltransferasesIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Long Noncoding RNAIBA 10/2020
1	Gefitinib (Iressa)FDA Link 05/2020
1	osimertinibIBA 05/2020
1	anlotinibIBA 05/2020
1	cabozantinibIBA 05/2020
1	Tyrosine Kinase InhibitorsIBA 05/2020
1	Explosive Agents (Explosives)IBA 05/2020
1	Gemcitabine FDA Link 12/2019
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	ParaffinIBA 01/2018
1	Chemokine ReceptorsIBA 12/2017
1	MicroRNAs (MicroRNA)IBA 10/2017
1	Sodium-Glucose Transporter 2 InhibitorsIBA 05/2014
1	1- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 1,6- dideoxyglucopyranoseIBA 05/2014
1	Glucose (Dextrose)FDA LinkGeneric 05/2014
1	SodiumIBA 05/2014

Therapy/Procedure

1	Therapeutics 01/2023